文献速递心境障碍

抑郁症缓解后脑连接变化:药物与心理治疗共享及独特模式

Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy.
PubMed 文献 · Am J Psychiatry · 2023-01-18

该研究基于PReDICT试验,对未用药重性抑郁障碍成人随机给予12周认知行为治疗(CBT)或药物治疗,比较缓解者静息态功能连接(rsFC)变化。缓解者中观察到三种连接变化模式:共享的膝下扣带回与运动皮层连接降低、多数治疗特异的互反变化、以及仅CBT缓解者执行控制网络内及与顶叶注意区连接增强。结论认为缓解相关rsFC变化多具治疗特异性,为换药或联合治疗提供生物学支持。

要点

  • CBT与药物缓解者共享膝下扣带回-运动皮层rsFC降低。
  • 多数网络rsFC变化呈治疗特异互反模式:CBT缓解者增、药物缓解者减。
  • 仅CBT缓解者执行控制网络内及与顶叶注意区rsFC增强。

核心结论

  • 重性抑郁经CBT或药物缓解均伴随rsFC变化,且变化大多为治疗方式特异。
  • 药物缓解与广泛抑制性效应相关,CBT缓解者认知控制与注意网络连接增强支持CBT理论机制。
  • 降低情感网络与运动系统连接是两种治疗缓解的共享过程。

研究设计与样本

  • PReDICT试验将未用药重性抑郁障碍成人随机分配至12周CBT(16次1小时会谈)或药物治疗(度洛西汀30-60 mg/日或艾司西酞普兰10-20 mg/日)。
  • 基线与第12周进行静息态功能MRI,主要结局为缓解者四个种子脑网络全脑rsFC变化。
  • 131名完成者具可用MRI数据(74名女性;平均年龄39.8岁),CBT组40例中19例缓解,药物组91例中45例缓解。

主要发现

  • 缓解者共享膝下扣带回皮层与运动皮层之间rsFC降低模式。
  • 多个网络间rsFC呈互反变化,主要为CBT缓解者增加、药物缓解者降低。
  • 仅CBT缓解者执行控制网络内及执行控制网络与顶叶注意区之间rsFC增加。

临床怎么用

  • CBT与药物缓解相关的脑连接变化多具治疗特异性,为临床换用或联合两种治疗提供生物学支持。
  • 药物缓解与广泛抑制性效应相关,CBT缓解者认知控制与注意网络连接增强支持CBT机制。
  • 降低情感网络与运动系统连接是两种治疗缓解的共享过程,可能作为缓解的共同靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The authors sought to determine the shared and unique changes in brain resting-state functional connectivity (rsFC) between patients with major depressive disorder who achieved remission with cognitive-behavioral therapy (CBT) or with antidepressant medication. METHODS: The Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) trial randomized adults with treatment-naive major depressive disorder to 12 weeks of treatment with CBT (16 1-hour sessions) or medication (duloxetine 30-60 mg/day or escitalopram 10-20 mg/day). Resting-state functional MRI scans were performed at baseline and at week 12. The primary outcome was change in the whole-brain rsFC of four seeded brain networks among participants who achieved remission. RESULTS: Of the 131 completers with usable MRI data (74 female; mean age, 39.8 years), remission was achieved by 19 of 40 CBT-treated and 45 of 91 medication-treated patients. Three patterns of connectivity changes were observed. First, those who remitted with either treatment shared a pattern of reduction in rsFC between the subcallosal cingulate cortex and the motor cortex. Second, reciprocal rsFC changes were observed across multiple networks, primarily increases in CBT remitters and decreases in medication remitters. And third, in CBT remitters only, rsFC increased within the executive control network and between the executive control network and parietal attention regions. CONCLUSIONS: Remission from major depression via treatment with CBT or medication is associated with changes in rsFC that are mostly specific to the treatment modality, providing biological support for the clinical practice of switching between or combining these treatment approaches. Medication is associated with broadly inhibitory effects. In CBT remitters, the increase in rsFC strength between networks involved in cognitive control and attention provides biological support for the theorized mechanism of CBT. Reducing affective network connectivity with motor systems is a shared process important for remission with both CBT and medication.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Dunlop BW, Cha J, Choi KS, et al. Shared and Unique Changes in Brain Connectivity Among Depressed Patients After Remission With Pharmacotherapy Versus Psychotherapy. Am J Psychiatry. 2023. PMID: 36651624. doi:10.1176/appi.ajp.21070727

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。